Literature DB >> 26164462

Enriched rat primary ventral mesencephalic neurons as an in-vitro culture model.

Venkata S Bollimpelli1, Anand K Kondapi.   

Abstract

Primary ventral mesencephalic (VM) neuronal cultures are gaining importance in the study of molecular mechanisms leading to Parkinson's disease and development of treatment strategies. In practice, these neurons are cocultured with glial cells, making assessment of neuronal specific proteomic and genomic analyses difficult. Hence, development of VM neuron-enriched culture is indispensable for such analyses. In the current study, VM neurons with less than 5% of glial cells in culture were found to survive for 9 days in vitro (DIV), followed by a sudden death phase resulting in less than 5% of neuronal viability. Analysis of expression of precursor and mature neuronal markers, Nestin and MAP-2, respectively, has shown that these VM neurons attain maturity at the 7th DIV both in the presence and in the absence of glial cells. This VM neuron-enriched culture was shown to be rich in dopaminergic neurons from 7th DIV and survived up to 10th DIV. Reactive oxygen species and DNA damage estimated using CMH2CDFDA dye and comet assay, respectively, showed an increase in their respective levels at 9th DIV. Furthermore, expression of topoisomerase II β, a key player in neuronal development, was found to increase until 9th DIV, followed by a sudden decrease on 10th DIV. In conclusion, the above results provide a good working model of VM neurons in vitro along with 7th DIV as an ideal time period to study and evaluate the pro/antisurvival effects of various compounds on VM neurons.
Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26164462     DOI: 10.1097/WNR.0000000000000420

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  5 in total

1.  TGF-β1 Neuroprotection via Inhibition of Microglial Activation in a Rat Model of Parkinson's Disease.

Authors:  Xiao Chen; Zhan Liu; Bei-Bei Cao; Yi-Hua Qiu; Yu-Ping Peng
Journal:  J Neuroimmune Pharmacol       Date:  2017-04-20       Impact factor: 4.147

2.  Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson's Disease Models.

Authors:  Bingxu Huang; Juxiong Liu; Chen Ju; Dongxue Yang; Guangxin Chen; Shiyao Xu; Yalong Zeng; Xuan Yan; Wei Wang; Dianfeng Liu; Shoupeng Fu
Journal:  Int J Mol Sci       Date:  2017-09-22       Impact factor: 5.923

3.  NCX1 and NCX3 as potential factors contributing to neurodegeneration and neuroinflammation in the A53T transgenic mouse model of Parkinson's Disease.

Authors:  Rossana Sirabella; Maria Josè Sisalli; Giulia Costa; Katia Omura; Gaetano Ianniello; Annalisa Pinna; Micaela Morelli; Gianfranco Maria Di Renzo; Lucio Annunziato; Antonella Scorziello
Journal:  Cell Death Dis       Date:  2018-06-25       Impact factor: 8.469

4.  Inhibition of TYRO3/Akt signaling participates in hypoxic injury in hippocampal neurons.

Authors:  Yan-Zhen Zhu; Wei Wang; Na Xian; Bing Wu
Journal:  Neural Regen Res       Date:  2016-05       Impact factor: 5.135

5.  Activation of α7 nAChR by PNU-282987 improves synaptic and cognitive functions through restoring the expression of synaptic-associated proteins and the CaM-CaMKII-CREB signaling pathway.

Authors:  Xiao-Ling Wang; Yu-Xin Deng; Yu-Mei Gao; Yang-Ting Dong; Fan Wang; Zhi-Zhong Guan; Wei Hong; Xiao-Lan Qi
Journal:  Aging (Albany NY)       Date:  2020-01-06       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.